Pharmaceutical Pricing: Dynamics In A Global Market
Published: 19 Apr 2010
- 20 pages
- PDF delivery via email, hard copies via first-class mail
Catalogue Price: $580.00
Web Price: $490.00
You save: $90.00 (15%) on the regular rate
Product Description
Business Monitor International (BMI)'s special report `Pharmaceutical Pricing: Dynamics In A Global Market' analyses variations in consumer price indices from 40 countries, identifying historic and likely future trends in the price evolution of pharmaceutical products.
The report covers the impact of key events such as regulatory reforms, economic fluctuations and differing levels of control over prices on a global basis, with a particular focus on key developed states and the high potential BRIC (Brazil, Russia, India, China) emerging markets.
Key Findings
- Pharmaceutical prices have typically increased at a rate below the general Consumer Price Index in both developed and emerging markets, despite differing regulatory controls and financing methods.
- Pharmaceutical inflation is considerably higher and shows wider deviations in emerging markets than developed states.
- Few pharmaceutical companies in emerging markets have increased prices in line with inflation, despite a lack of price controls in many emerging markets.
- Pharmaceutical prices will show increasingly lower rates of inflation, due to increased implementation of regulatory controls to stem growth in expenditure.
- Price pressures will be a major downwards force on pharmaceutical sales growth in the short- and long-term.
